What is the price target for KRMD stock?
11 analysts have analysed KRMD and the average price target is 6.94 USD. This implies a price increase of 63.58% is expected in the next year compared to the current price of 4.24.
NASDAQ:KRMD • US7599101026
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KORU MEDICAL SYSTEMS INC (KRMD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-13 | B. Riley Securities | Maintains | Buy -> Buy |
| 2026-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-22 | Lake Street | Maintains | Buy -> Buy |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-08 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-14 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-01-17 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-01-14 | Lake Street | Maintains | Buy -> Buy |
| 2024-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-14 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-14 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2023-12-07 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-09-07 | Lake Street | Initiate | Buy |
| 2023-09-07 | B. Riley Securities | Initiate | Buy |
| 2023-08-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-01-06 | Piper Sandler | Maintains | Overweight |
| 2022-11-10 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2022-11-10 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.518M 2.21% | 33.647M 17.98% | 41.127M 22.23% | 49.446M 20.23% | 57.904M 17.11% | 65.586M 13.27% | |
| EBITDA YoY % growth | -9.4M 7.76% | -5.558M 40.87% | -2.162M 61.10% | 3.175M 246.86% | 6.568M 106.87% | N/A | |
| EBIT YoY % growth | -10.27M 4.73% | -6.446M 37.23% | -2.972M 53.89% | -1.083M 63.56% | 1.9M 275.43% | 5.406M 184.53% | |
| Operating Margin | -36.01% | -19.16% | -7.23% | -2.19% | 3.28% | 8.24% | |
| EPS YoY % growth | -0.16 20.00% | -0.10 37.50% | N/A 66.85% | 0.02 146.15% | 0.06 322.00% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 -2.00% | -0.01 | 0.00 79.60% | 0.00 100.00% | 0.01 133.35% | 0.01 200.00% | 0.02 516.75% | 0.02 | 0.03 349.78% | 0.04 300.00% | 0.05 199.94% | 0.06 157.18% |
| Revenue Q2Q % growth | 11.51M 19.46% | 12.081M 18.50% | 12.526M 20.42% | 13.329M 22.34% | 13.634M 18.45% | 14.314M 18.48% | 14.858M 18.62% | 15.708M 17.85% | 15.3M 12.22% | 16.014M 11.88% | 16.728M 12.59% | 17.442M 11.04% |
| EBITDA Q2Q % growth | 110.976K 110.80% | 418.2K 266.52% | 655.044K 377.09% | 1.026M 289.52% | 1.02M 819.12% | 1.326M 217.07% | 1.53M 133.57% | 1.938M 88.89% | 1.734M 70.00% | 2.142M 61.54% | 2.652M 73.33% | 3.06M 57.89% |
| EBIT Q2Q % growth | -918.612K 26.22% | -572.628K -83.12% | -210.528K 75.74% | -69.156K 87.36% | 102K 111.10% | 255K 144.53% | 612K 390.70% | 1.02M 1,574.93% | 714K 600.00% | 1.122M 340.00% | 1.632M 166.67% | 1.938M 90.00% |
All data in USD
11 analysts have analysed KRMD and the average price target is 6.94 USD. This implies a price increase of 63.58% is expected in the next year compared to the current price of 4.24.
KORU MEDICAL SYSTEMS INC (KRMD) will report earnings on 2026-05-11, after the market close.
The consensus EPS estimate for the next earnings of KORU MEDICAL SYSTEMS INC (KRMD) is -0.02 USD and the consensus revenue estimate is 11.51M USD.
The number of analysts covering KORU MEDICAL SYSTEMS INC (KRMD) is 11.